Advertisement
Screener

BOSTON SCIENTIFIC CORPORATION (BSX) Cash and Cash Equivalents, Period Increase (Decrease)

3.0 / 5 stars · 73/120 Roast Me

BOSTON SCIENTIFIC CORPORATION Cash and Cash Equivalents, Period Increase (Decrease)

BOSTON SCIENTIFIC CORPORATION (BSX) reported Cash and Cash Equivalents, Period Increase (Decrease) of $14.00 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-02.

Discontinued › Cash Flow › Change in Cash

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2017-11-02

  • BOSTON SCIENTIFIC CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was $15.00M.
  • BOSTON SCIENTIFIC CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was $39.00M, a 61.00% decline year-over-year.
  • BOSTON SCIENTIFIC CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was -$40.00M, a 310.53% decline year-over-year.
  • BOSTON SCIENTIFIC CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2016-12-31 was -$41.00M.
  • BOSTON SCIENTIFIC CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$123.00M.
  • BOSTON SCIENTIFIC CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$268.00M, a 172.43% decline from fiscal 2014.
  • BOSTON SCIENTIFIC CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2014 was $370.00M, a 3600.00% increase from fiscal 2013.
  • BOSTON SCIENTIFIC CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2013 was $10.00M.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 12 month
2017-09-30$15.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
$54.00M
derived: sum of 2 quarters · filed 2017-11-02
$14.00M
10-Q · filed 2017-11-02
-$27.00M
derived: sum of 4 quarters · filed 2017-11-02
2017-06-30$39.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
-$1.00M
10-Q · filed 2017-08-03
-$42.00M
derived: sum of 3 quarters · filed 2017-08-03
-$243.00M
derived: sum of 4 quarters · filed 2017-11-02
2017-03-31-$40.00M
10-Q · filed 2017-05-03
-$81.00M
derived: sum of 2 quarters · filed 2017-05-03
-$282.00M
derived: sum of 3 quarters · filed 2017-11-02
-$182.00M
derived: sum of 4 quarters · filed 2017-11-02
2016-12-31-$41.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
-$242.00M
derived: sum of 2 quarters · filed 2017-11-02
-$142.00M
derived: sum of 3 quarters · filed 2017-11-02
-$123.00M
10-K · filed 2017-02-23
2016-09-30-$201.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
-$101.00M
derived: sum of 2 quarters · filed 2017-11-02
-$82.00M
10-Q · filed 2017-11-02
-$113.00M
derived: sum of 4 quarters · filed 2017-11-02
2016-06-30$100.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
$119.00M
10-Q · filed 2017-08-03
$88.00M
derived: sum of 3 quarters · filed 2017-08-03
-$465.00M
derived: sum of 4 quarters · filed 2017-08-03
2016-03-31$19.00M
10-Q · filed 2017-05-03
-$12.00M
derived: sum of 2 quarters · filed 2017-05-03
-$565.00M
derived: sum of 3 quarters · filed 2017-05-03
$96.00M
derived: sum of 4 quarters · filed 2017-05-03
2015-12-31-$31.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
-$584.00M
derived: sum of 2 quarters · filed 2017-02-23
$77.00M
derived: sum of 3 quarters · filed 2017-02-23
-$268.00M
10-K · filed 2017-02-23
2015-09-30-$553.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$108.00M
derived: sum of 2 quarters · filed 2016-11-03
-$237.00M
10-Q · filed 2016-11-03
$104.00M
derived: sum of 4 quarters · filed 2017-02-23
2015-06-30$661.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03
$316.00M
10-Q · filed 2016-08-03
$657.00M
derived: sum of 3 quarters · filed 2017-02-23
$546.00M
derived: sum of 4 quarters · filed 2017-02-23
2015-03-31-$345.00M
10-Q · filed 2016-05-04
-$4.00M
derived: sum of 2 quarters · filed 2017-02-23
-$115.00M
derived: sum of 3 quarters · filed 2017-02-23
$51.00M
derived: sum of 4 quarters · filed 2017-02-23
2014-12-31$341.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
$230.00M
derived: sum of 2 quarters · filed 2017-02-23
$396.00M
derived: sum of 3 quarters · filed 2017-02-23
$370.00M
10-K · filed 2017-02-23
2014-09-30-$111.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04
$55.00M
derived: sum of 2 quarters · filed 2015-11-04
$29.00M
10-Q · filed 2015-11-04
-$325.00M
derived: sum of 4 quarters · filed 2016-02-24
2014-06-30$166.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$140.00M
10-Q · filed 2015-08-06
-$214.00M
derived: sum of 3 quarters · filed 2016-02-24
-$173.00M
derived: sum of 4 quarters · filed 2016-02-24
2014-03-31-$26.00M
10-Q · filed 2015-05-06
-$380.00M
derived: sum of 2 quarters · filed 2016-02-24
-$339.00M
derived: sum of 3 quarters · filed 2016-02-24
-$77.00M
derived: sum of 4 quarters · filed 2016-02-24
2013-12-31-$354.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24
-$313.00M
derived: sum of 2 quarters · filed 2016-02-24
-$51.00M
derived: sum of 3 quarters · filed 2016-02-24
$10.00M
10-K · filed 2016-02-24
2013-09-30$41.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05
$303.00M
derived: sum of 2 quarters · filed 2014-11-05
$364.00M
10-Q · filed 2014-11-05
$219.00M
derived: sum of 4 quarters · filed 2015-02-25
2013-06-30$262.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06
$323.00M
10-Q · filed 2014-08-06
$178.00M
derived: sum of 3 quarters · filed 2015-02-25
$159.00M
derived: sum of 4 quarters · filed 2015-02-25
2013-03-31$61.00M
10-Q · filed 2014-05-08
-$84.00M
derived: sum of 2 quarters · filed 2015-02-25
-$103.00M
derived: sum of 3 quarters · filed 2015-02-25
-$16.00M
derived: sum of 4 quarters · filed 2015-02-25
2012-12-31-$145.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25
-$164.00M
derived: sum of 2 quarters · filed 2015-02-25
-$77.00M
derived: sum of 3 quarters · filed 2015-02-25
-$60.00M
10-K · filed 2015-02-25
2012-09-30-$19.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05
$68.00M
derived: sum of 2 quarters · filed 2013-11-05
$85.00M
10-Q · filed 2013-11-05
$76.00M
derived: sum of 4 quarters · filed 2014-02-26
2012-06-30$87.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07
$104.00M
10-Q · filed 2013-08-07
$95.00M
derived: sum of 3 quarters · filed 2014-02-26
$217.00M
derived: sum of 4 quarters · filed 2014-02-26
2012-03-31$17.00M
10-Q · filed 2013-05-07
$8.00M
derived: sum of 2 quarters · filed 2014-02-26
$130.00M
derived: sum of 3 quarters · filed 2014-02-26
-$311.00M
derived: sum of 4 quarters · filed 2014-02-26
2011-12-31-$9.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26
$113.00M
derived: sum of 2 quarters · filed 2014-02-26
-$328.00M
derived: sum of 3 quarters · filed 2014-02-26
$54.00M
10-K · filed 2014-02-26
2011-09-30$122.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06
-$319.00M
derived: sum of 2 quarters · filed 2012-11-06
$63.00M
10-Q · filed 2012-11-06
-$348.00M
derived: sum of 4 quarters · filed 2013-05-29
2011-06-30-$441.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07
-$59.00M
10-Q · filed 2012-08-07
-$470.00M
derived: sum of 3 quarters · filed 2013-05-29
-$657.00M
derived: sum of 4 quarters · filed 2013-05-29
2011-03-31$382.00M
10-Q · filed 2012-05-03
-$29.00M
derived: sum of 2 quarters · filed 2013-05-29
-$216.00M
derived: sum of 3 quarters · filed 2013-05-29
$76.00M
derived: sum of 4 quarters · filed 2013-05-29
2010-12-31-$411.00M
derived: 8-K 12 month − 10-Q 9 month · filed 2013-05-29
-$598.00M
derived: sum of 2 quarters · filed 2013-05-29
-$306.00M
derived: sum of 3 quarters · filed 2013-05-29
-$651.00M
8-K · filed 2013-05-29
2010-09-30-$187.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08
$105.00M
derived: sum of 2 quarters · filed 2011-11-08
-$240.00M
10-Q · filed 2011-11-08
-$757.00M
derived: sum of 4 quarters · filed 2012-02-17
2010-06-30$292.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05
-$53.00M
10-Q · filed 2011-08-05
-$570.00M
derived: sum of 3 quarters · filed 2012-02-17
-$383.00M
derived: sum of 4 quarters · filed 2012-02-17
2010-03-31-$345.00M
10-Q · filed 2011-05-05
-$862.00M
derived: sum of 2 quarters · filed 2012-02-17
-$675.00M
derived: sum of 3 quarters · filed 2012-02-17
-$378.00M
derived: sum of 4 quarters · filed 2012-02-17
2009-12-31-$517.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17
-$330.00M
derived: sum of 2 quarters · filed 2012-02-17
-$33.00M
derived: sum of 3 quarters · filed 2012-02-17
-$777.00M
10-K · filed 2012-02-17
2009-09-30$187.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05
$484.00M
derived: sum of 2 quarters · filed 2010-11-05
-$260.00M
10-Q · filed 2010-11-05
-$353.00M
derived: sum of 4 quarters · filed 2011-02-17
2009-06-30$297.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-05
-$447.00M
10-Q · filed 2010-08-05
-$540.00M
derived: sum of 3 quarters · filed 2011-02-17
-$422.00M
derived: sum of 4 quarters · filed 2011-02-17
2009-03-31-$744.00M
10-Q · filed 2010-05-06
-$837.00M
derived: sum of 2 quarters · filed 2011-02-17
-$719.00M
derived: sum of 3 quarters · filed 2011-02-17
2008-12-31-$93.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-17
$25.00M
derived: sum of 2 quarters · filed 2011-02-17
$189.00M
10-K · filed 2011-02-17
2008-09-30$118.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-06
$282.00M
10-Q · filed 2009-11-06
2008-06-30$164.00M
10-Q · filed 2009-08-06
2007-12-31-$216.00M
10-K · filed 2010-02-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
BECTON DICKINSON & CO (BDX)United States$48.834B43.79
3M CO (MMM)United States$86.404B27.87
DEXCOM INC (DXCM)United States$33.004B25.42
WEST PHARMACEUTICAL SERVICES INC (WST)United States$26.288B43.14
STRYKER CORP (SYK)United States$103.511B32.39
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12